Shirasawa S - Search Results

1

Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.

Shahrzad S, Quayle L, Stone C, Plumb C, Shirasawa S, Rak JW, Coomber BL. Shahrzad S, et al. Among authors: shirasawa s. Cancer Res. 2005 Sep 15;65(18):8134-41. doi: 10.1158/0008-5472.CAN-05-0713. Cancer Res. 2005. PMID: 16166287

2

Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.

Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS. Rak J, et al. Among authors: shirasawa s. Cancer Res. 1995 Oct 15;55(20):4575-80. Cancer Res. 1995. PMID: 7553632

3

Activated Ki-ras enhances sensitivity of ceramide-induced apoptosis without c-Jun NH2-terminal kinase/stress-activated protein kinase or extracellular signal-regulated kinase activation in human colon cancer cells.

Ohmori M, Shirasawa S, Furuse M, Okumura K, Sasazuki T. Ohmori M, et al. Among authors: shirasawa s. Cancer Res. 1997 Nov 1;57(21):4714-7. Cancer Res. 1997. PMID: 9354428

4

Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells.

Okada F, Rak JW, Croix BS, Lieubeau B, Kaya M, Roncari L, Shirasawa S, Sasazuki T, Kerbel RS. Okada F, et al. Among authors: shirasawa s. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3609-14. doi: 10.1073/pnas.95.7.3609. Proc Natl Acad Sci U S A. 1998. PMID: 9520413 Free PMC article.

5

Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.

Okumura K, Shirasawa S, Nishioka M, Sasazuki T. Okumura K, et al. Among authors: shirasawa s. Cancer Res. 1999 May 15;59(10):2445-50. Cancer Res. 1999. PMID: 10344756

6

Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.

Long IS, Han K, Li M, Shirasawa S, Sasazuki T, Johnston M, Tsao MS. Long IS, et al. Among authors: shirasawa s. Mol Cancer Res. 2003 Mar;1(5):393-401. Mol Cancer Res. 2003. PMID: 12651912

7

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis.

Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, Coomber BL, Mackman N, Rak JW. Yu JL, et al. Among authors: shirasawa s. Blood. 2005 Feb 15;105(4):1734-41. doi: 10.1182/blood-2004-05-2042. Epub 2004 Oct 19. Blood. 2005. PMID: 15494427 Free article.

8

Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.

Pollock CB, Shirasawa S, Sasazuki T, Kolch W, Dhillon AS. Pollock CB, et al. Among authors: shirasawa s. Cancer Res. 2005 Feb 15;65(4):1244-50. doi: 10.1158/0008-5472.CAN-04-1911. Cancer Res. 2005. PMID: 15735008

9

KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand.

Smakman N, van den Wollenberg DJ, Elias SG, Sasazuki T, Shirasawa S, Hoeben RC, Borel Rinkes IH, Kranenburg O. Smakman N, et al. Among authors: shirasawa s. Cancer Res. 2006 May 15;66(10):5403-8. doi: 10.1158/0008-5472.CAN-05-4108. Cancer Res. 2006. PMID: 16707468

10

Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.

Cleynen I, Huysmans C, Sasazuki T, Shirasawa S, Van de Ven W, Peeters K. Cleynen I, et al. Among authors: shirasawa s. Cancer Res. 2007 May 15;67(10):4620-9. doi: 10.1158/0008-5472.CAN-06-4325. Cancer Res. 2007. PMID: 17510387 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page